Adial Pharmaceuticals adjourns meeting
- Meeting adjourned until Oct 26, 2026
- Nasdaq approval pending for proposals 3-6
- Proxies already submitted do not need action
Every EDGAR filing for ADIAL PHARMACEUTICALS, INC. (ADIL), newest first, with AI summaries and stories.
Next: 10-Q expected ~Nov 13 (deadline Nov 16) · earnings expected ~Nov 16
No open-market insider buys in the last 30 days.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Wendy B. Young, insider filing for ADIL
Wendy B. Young, reporting
Coastlands Capital LP, insider filing for ADIL
Coastlands Capital LP, reporting
Coastlands Capital LP, insider filing for ADIL
Coastlands Capital LP, reporting
Ownership stake disclosure by Coastlands Capital LP (amended)
Coastlands Capital LP, filed by
Coastlands Capital LP, insider filing for ADIL
Coastlands Capital LP, reporting
Coastlands Capital LP, new insider at ADIL
Coastlands Capital LP, reporting
Ownership stake disclosure by Coastlands Capital LP
Coastlands Capital LP, filed by
Matt Davidson, insider filing for ADIL
Matt Davidson, reporting
Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)
ARMISTICE CAPITAL, LLC, filed by
Vinay Shah, insider filing for ADIL
Vinay Shah, reporting
Ownership stake disclosure by ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC, filed by